Who
James J. Marino
Director
Company insider
Files Form 4 as: Director, Celldex Therapeutics; Director, Traws Pharma; Director, Pharmacopeia Drug Discovery.
In numbers
- Trades disclosed
- 45
- Buys
- 10
- Sells
- 0
- Bought
- $171K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 4 May 2006
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 18 Nov 2024filed 20 Nov 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code G | —10,500 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 10 Aug 2023filed 14 Aug 2023 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,468 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,300 at $0.00 | filing |
| 18 Aug 2022filed 19 Aug 2022 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,468 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —13,600 at $0.00 | filing |
| 28 Sep 2021filed 28 Sep 2021 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Bought | $25K5,952 at $4.20 | filing |
| 30 Jul 2021filed 30 Jul 2021 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 17 Jun 2021filed 21 Jun 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 16 Feb 2021filed 17 Feb 2021 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Bought | $25K25,000 at $1.00 | filing |
| 24 Nov 2020filed 27 Nov 2020 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Bought | $10K38,774 at $0.26 | filing |
| 9 Jul 2020filed 10 Jul 2020 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 9 Jun 2020filed 10 Jun 2020 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $25K8,305 at $3.00 | filing |
| 25 Nov 2019filed 26 Nov 2019 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —150,000 | filing |
| 25 Nov 2019filed 26 Nov 2019 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Bought | $30K150,000 at $0.20 | filing |
| 25 Sep 2019filed 26 Sep 2019 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code H | —5,000 | filing |
News
No headline names them, or the companies they trade most, lately.